Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20963 | 25617046 | Expert Rev Gastroenterol Hepatol | Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A20964 | 25616307 | Zhongguo Dang Dai Er Ke Za Zhi | [Research advances in pediatric nonalcoholic fatty liver disease]. | 2015 | Details |
| A20965 | 25614616 | QJM | Association between non-alcoholic fatty liver disease and autonomic dysfunction in a Chinese population. | 2015 | Details |
| A20966 | 25614396 | J Ultrasound Med | Spleen size in cirrhosis of different etiologies. | 2015 | Details |
| A20967 | 25614040 | J Spinal Cord Med | Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury. | 2016 | Details |
| A20971 | 25611978 | J Viral Hepat | HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients. | 2015 | Details |
| A20972 | 25609476 | Sci Rep | Potent effects of dioscin against obesity in mice. | 2015 | Details |
| A20973 | 25609431 | FASEB J | Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH. | 2015 | Details |
| A20974 | 25608776 | Ann Gastroenterol | Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis. | 2020 | Details |
| A20975 | 25607821 | Oncol Rep | Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis. | 2015 | Details |
| A20976 | 25606452 | Meta Gene | Genetic polymorphism of the human organic solute carrier protein 1 (hOSCP1) gene in Japanese patients with non-viral liver carcinoma. | 2014 | Details |
| A20977 | 25606341 | Med Gas Res | Exogenous hydrogen sulfide mitigates the fatty liver in obese mice through improving lipid metabolism and antioxidant potential. | 2015 | Details |
| A20978 | 25606030 | Case Rep Gastroenterol | A 25-year-old woman with type 2 diabetes and liver disease. | 2014 | Details |
| A20979 | 25605429 | Int J Mol Med | miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR. | 2015 | Details |
| A20980 | 25605057 | Int J Mol Med | Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. | 2015 | Details |
| A20981 | 25604802 | Expert Opin Investig Drugs | Early investigational drugs targeting PPAR-α for the treatment of metabolic disease. | 2015 | Details |
| A20982 | 25603556 | Biochim Biophys Acta | Palmitate activation by fatty acid transport protein 4 as a model system for hepatocellular apoptosis and steatosis. | 2015 | Details |
| A20983 | 25603326 | Rev Esp Enferm Dig | Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis. | 2015 | Details |
| A20985 | 25602171 | Antioxid Redox Signal | Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. | 2015 | Details |
| A20986 | 25601465 | Curr Mol Med | Understanding nutritional interventions and physical exercise in non-alcoholic fatty liver disease. | 2015 | Details |
| A20989 | 25600030 | Curr Vasc Pharmacol | Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment. | 2015 | Details |
| A20991 | 25598995 | J Clin Exp Cardiolog | Association between inflammatory markers and liver fat: The Multi-Ethnic Study of Atherosclerosis. | 2022 | Details |
| A20992 | 25598791 | Hepat Mon | Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis. | 2014 | Details |
| A20993 | 25598080 | J Lipid Res | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. | 2015 | Details |
| A20994 | 25597287 | Exp Mol Pathol | A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity. | 2015 | Details |
| A20995 | 25597144 | J Egypt Soc Parasitol | Pharmacological and antioxidant actions of garlic and.or onion in non-alcoholic fatty liver disease (NAFLD) in rats. | 2014 | Details |
| A20996 | 25595882 | J Hepatol | Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis. | 2015 | Details |
| A20997 | 25593466 | World J Gastroenterol | miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease. | 2015 | Details |
| A20998 | 25592661 | Clin Gastroenterol Hepatol | Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis. | 2015 | Details |
| A20999 | 25591123 | J Pediatr Gastroenterol Nutr | Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement. | 2015 | Details |
| A21000 | 25590055 | Biol Pharm Bull | Efficacy and safety of human placental extract for alcoholic and nonalcoholic steatohepatitis: an open-label, randomized, comparative study. | 2014 | Details |
| A21002 | 25587525 | Pediatr Gastroenterol Hepatol Nutr | The clinical significance of serum ferritin in pediatric non-alcoholic Fatty liver disease. | 2014 | Details |
| A21003 | 25585400 | IEEE Trans Ultrason Ferroelectr Freq Control | Derivation and analysis of viscoelastic properties in human liver: impact of frequency on fibrosis and steatosis staging. | 2015 | Details |
| A21004 | 25583095 | Clin Biochem | Laboratory assessment of cardiometabolic risk in overweight and obese children. | 2015 | Details |
| A21005 | 25581590 | Analyst | Vibrational signatures to discriminate liver steatosis grades. | 2015 | Details |
| A21006 | 25581573 | Liver Int | TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism. | 2015 | Details |
| A21007 | 25581263 | Hepatology | Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. | 2015 | Details |
| A21008 | 25581125 | Hepatol Res | Alleviation mechanisms against hepatocyte oxidative stress in patients with chronic hepatic disorders. | 2015 | Details |
| A21009 | 25580206 | Frontline Gastroenterol | Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. | 2014 | Details |
| A21011 | 25577467 | J Nutr Biochem | Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. | 2014 | Details |
| A21012 | 25577300 | Dig Liver Dis | Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. | 2014 | Details |
| A21013 | 25576488 | Mol Pharmacol | Repression of the nuclear receptor small heterodimer partner by steatotic drugs and in advanced nonalcoholic fatty liver disease. | 2015 | Details |
| A21014 | 25576095 | J Nutr Biochem | Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic programming in offspring. | 2014 | Details |
| A21015 | 25575848 | Clin J Gastroenterol | Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies. | 2015 | Details |
| A21016 | 25575598 | J Biol Chem | Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion. | 2015 | Details |
| A21017 | 25575111 | Can J Gastroenterol Hepatol | Biomarkers in nonalcoholic fatty liver disease. | 2014 | Details |
| A21018 | 25574593 | Diabetes Technol Ther | Relationship between β-cell function, metabolic control, and microvascular complications in type 2 diabetes mellitus. | 2015 | Details |
| A21019 | 25574453 | Curr Pathobiol Rep | Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players. | 2014 | Details |
| A21020 | 25574105 | World J Gastroenterol | Fatty acid changes help to better understand regression of nonalcoholic fatty liver disease. | 2015 | Details |
| A21021 | 25573175 | Am J Physiol Gastrointest Liver Physiol | Chronic NOS inhibition accelerates NAFLD progression in an obese rat model. | 2015 | Details |
| A21022 | 25573131 | Zhonghua Yu Fang Yi Xue Za Zhi | [Study of synergistic effect of free fatty acid and iron on the establishment of nonalcoholic fatty liver disease model]. | 2014 | Details |
| A21023 | 25571645 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis]. | 2014 | Details |
| A21024 | 25568861 | Hepatobiliary Surg Nutr | Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease. | 2014 | Details |
| A21025 | 25567295 | Clin Pediatr (Phila) | The full spectrum of hepatic steatosis in children. | 2015 | Details |
| A21026 | 25566323 | Front Genet | TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease. | 2014 | Details |
| A21027 | 25566193 | Front Endocrinol (Lausanne) | O-GlcNAc: A Bittersweet Switch in Liver. | 2014 | Details |
| A21028 | 25566190 | Front Endocrinol (Lausanne) | Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice. | 2014 | Details |
| A21033 | 25564761 | J Dig Dis | Long-term outcomes after hospitalization with spontaneous bacterial peritonitis. | 2015 | Details |
| A21034 | 25564638 | BMJ Case Rep | Resolution of NASH with weight loss documented by hepatic MRI. | 2015 | Details |
| A21035 | 25563215 | Eur J Pediatr | The intestinal microbiota: its role in health and disease. | 2015 | Details |
| A21036 | 25563143 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. | 2015 | Details |
| A21037 | 25562616 | Endocrinology | Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin. | 2015 | Details |
| A21038 | 25562318 | J Clin Invest | Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. | 2014 | Details |
| A21039 | 25562147 | Cell Physiol Biochem | Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease. | 2014 | Details |
| A21040 | 25561963 | J Tehran Heart Cent | Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature review. | 2014 | Details |
| A21041 | 25561778 | World J Gastroenterol | Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. | 2014 | Details |
| A21043 | 25559574 | Endocrinol Metab (Seoul) | Comparison of serum ferritin and vitamin d in association with the severity of nonalcoholic Fatty liver disease in korean adults. | 2014 | Details |
| A21044 | 25559563 | J Gastroenterol Hepatol | MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice. | 2015 | Details |
| A21047 | 25557690 | Hepatology | Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop. | 2015 | Details |
| A21048 | 25556679 | Cell Mol Life Sci | Metabolic insights from zebrafish genetics, physiology, and chemical biology. | 2015 | Details |
| A21049 | 25554608 | Endokrynol Pol | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism. | 2014 | Details |
| A21050 | 25553983 | Eur J Intern Med | Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease. | 2014 | Details |
| A21051 | 25553772 | Expert Opin Drug Metab Toxicol | Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility. | 2015 | Details |
| A21054 | 25550952 | Int J Clin Exp Med | Assessment of hepatic steatosis on contrast enhanced computed tomography in patients with colorectal cancer. | 2014 | Details |
| A21055 | 25550930 | Int J Clin Exp Med | Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease. | 2014 | Details |
| A21057 | 25550397 | Circ Cardiovasc Imaging | Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease. | 2014 | Details |
| A21058 | 29201676 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Disease: Study of Demographic and Predictive Factors. | 2015 | Details |
| A21059 | 28596988 | J Diabetes Obes | NAFLD Susceptibility Genes and their Association with Type 2 Diabetes and Obesity in a New Mexico Population. | 2015 | Details |
| A21060 | 28356818 | J Med Biochem | Epidemiology and Natural History of NAFLD. | 2014 | Details |
| A21061 | 28356817 | J Med Biochem | Pediatric Non-Alcoholic Fatty Liver Disease. | 2014 | Details |
| A21062 | 27682116 | Microorganisms | Gut Microbiota and Host Reaction in Liver Diseases. | 2015 | Details |
| A21063 | 27508191 | J Hepatocell Carcinoma | A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma. | 2015 | Details |
| A21064 | 27453880 | J Diabetes Metab Disord | The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease. | 2016 | Details |
| A21065 | 27417789 | Healthcare (Basel) | Fatty Liver and Fatty Heart-Where do They Stand in the AMIS Syndrome? | 2015 | Details |
| A21066 | 27214983 | Eksp Klin Gastroenterol | [INSULIN-LIKE GROWTH FACTOR-1: THE INFLUENCE ON THE LIVER FUNCTION AND RELATIONSHIPS WITH RESISTIN IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND ITS COMBINATION WITH TYPE 2 DIABETES MELLITUS]. | 2015 | Details |
| A21067 | 27214981 | Eksp Klin Gastroenterol | [EFFICIENCY OF URSODEOXYCHOLIC ACID APPLICATION IN NONALCOCHOLIC STEATOHEPATITIS]. | 2015 | Details |
| A21068 | 27214980 | Eksp Klin Gastroenterol | [COURSE OF BILIARY SLUDGE ON THE BACKGROUND NON-ALCOHOLIC FATTY LIVER DISEASE]. | 2015 | Details |
| A21069 | 27188459 | Nat Rev Dis Primers | Nonalcoholic fatty liver disease. | 2015 | Details |
| A21070 | 27051920 | Eksp Klin Farmakol | [EFFECTS OF MELATONIN ON THE ACONITATE HYDRATASE ACTIVITY, CONTENT OF LIPID PEROXIDATION PRODUCTS AND SOME NON-ENZYMATIC ANTIOXIDANTS IN THE BLOOD OF PATIENTS WITH TYPE 2 DIABETES MELLITUS COMPLICATED BY STEATOHEPATITIS]. | 2015 | Details |
| A21071 | 26937432 | Eur J Radiol Open | Visual assessment of biliary excretion of Gd-EOB-DTPA in patients with suspected diffuse liver disease - A biopsy-verified prospective study. | 2015 | Details |
| A21072 | 26931016 | Eksp Klin Gastroenterol | [NON-ALCOHOLIC FATTY PANCREATIC DISEASE (NAFPD) AND THE METABOLIC SYNDROME: INITIATING FACTOR OR ADDITIONAL COMPONENT?]. | 2015 | Details |
| A21073 | 26931009 | Eksp Klin Gastroenterol | [CLINICAL FEATURE OF NONALCOHOLIC STEATOHEPATITIS, ASSOCIATED WITH CHRONIC CONSTIPATION]. | 2015 | Details |
| A21074 | 26931007 | Eksp Klin Gastroenterol | [THE CONTENT OF BILE ACIDS IN THE SERUM OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE]. | 2015 | Details |
| A21075 | 25548498 | World J Gastroenterol | Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content. | 2014 | Details |
| A21076 | 25548491 | World J Gastroenterol | Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. | 2014 | Details |
| A21077 | 25548489 | World J Gastroenterol | MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease. | 2014 | Details |
| A21078 | 25548482 | World J Gastroenterol | Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis. | 2014 | Details |
| A21079 | 25548472 | World J Gastroenterol | Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. | 2014 | Details |
| A21080 | 25547779 | Expert Opin Ther Targets | Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target. | 2014 | Details |
| A21081 | 25544877 | World J Hepatol | Vitamin D deficiency in chronic liver disease. | 2014 | Details |